±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 624  |  »Ø¸´: 3
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

mengzhongmeng

[½»Á÷] Éú»¯Ãû´Ê½âÊÍ

[color=][color=]µÚ¶þ²¿·Ö
µÚËÄÕÂ
1,άÉúËØ£¨vitamin£©:ÊÇÒ»ÀදÎï±¾Éí²»Äܺϳɣ¬µ«¶Ô¶¯ÎïÉú³¤ºÍ½¡¿µÓÖÊDZØÐèµÄÓлúÎËùÒÔ±ØÐè´ÓʳÎïÖлñµÃ¡£Ðí¶à¸¨Ã¸¶¼ÊÇÓÉάÉúËØÑÜÉúµÄ¡£
2£¬Ë®ÈÜÐÔάÉúËØ£¨water-soluble vitamin£©:Ò»ÀàÄÜÈÜÓÚË®µÄÓлúÓªÑø·Ö×Ó¡£ÆäÖаüÀ¨ÔÚøµÄ´ß»¯ÖÐÆð×ÅÖØÒª×÷ÓõÄB×åάÉúËØÒÔ¼°¿¹»µÑªËᣨάÉúËØC£©µÈ¡£
3£¬Ö¬ÈÜÐÔάÉúËØ£¨lipid vitamin£©:Óɳ¤µÄ̼ÇâÁ´»ò³í»·×é³ÉµÄ¾ÛÎì¶þÏ©»¯ºÏÎï¡£Ö¬ÈÜÐÔάÉúËØ°üÀ¨A£¬D£¬E£¬ºÍK£¬ÕâÀàάÉúËØÄܱ»¶¯ÎïÖü´æ¡£
4£¬¸¨Ã¸£¨conzyme£©:ijЩøÔÚ·¢»Ó´ß»¯×÷ÓÃʱËùÐèµÄÒ»ÀศÖúÒò×Ó£¬Æä³É·ÖÖÐÍùÍùº¬ÓÐάÉúËØ¡£¸¨Ã¸Óëø½áºÏËÉÉ¢£¬¿ÉÒÔͨ¹ý͸Îö³ýÈ¥¡£
5£¬¸¨»ù£¨prosthetic group£©:ÊÇÓëøµ°°×Öʹ²¼Û½áºÏµÄ½ðÊôÀë×Ó»òÒ»ÀàÓлú»¯ºÏÎÓÃ͸Îö·¨²»ÄܳýÈ¥¡£¸¨»ùÔÚÕû¸öø´Ù·´Ó¦¹ý³ÌÖÐʼÖÕÓëøµÄÌØ¶¨²¿Î»½áºÏ¡£
6,Äá¿Ëõ£°·ÏÙàÑßʶþºËÜÕËᣨNAD+£©ºÍÄá¿Ëõ£°·ÏÙàÑßʶþºËÜÕËáÁ×ËᣨNADP+£©:º¬ÓÐÄá¿Ëõ£°·µÄ¸¨Ã¸£¬ÔÚijЩÑõ»¯»¹Ô­ÖÐÆð×ÅÇâÔ­×Ӻ͵ç×ÓÔØÌåµÄ×÷Ó㬳£³£×÷ΪÍÑÇâøµÄ¸¨¡£
7£¬»ÆËص¥ºËÜÕËᣨFMN£©Ò»Öֺ˻ÆËØÁ×ËᣬÊÇijЩÑõ»¯»¹Ô­·´Ó¦µÄ¸¨Ã¸¡£
8£¬Áò°·Ëؽ¹Á×Ëᣨthiamine phosphate£©:ÊÇάÉúËØB1µÄ¸¨ÐÎʽ£¬²ÎÓëתȩ»ù·´Ó¦¡£
9£¬»ÆËØÏÙàÑßʶþºËÜÕËᣨFAD£©:ÊÇijЩÑõ»¯»¹Ô­·´Ó¦µÄ¸¨Ã¸£¬º¬Óк˻ÆËØ¡£
10£¬Á×ËáßÁ¶ßÈ©£¨pyidoxal phosphate£©:ÊÇάÉúËØB6£¨ßÁ¶ß´¼£©µÄÑÜÉúÎÊÇת°±Ã¸£¬ÍÑôÈøºÍÏûÐýøµÄø¡£
11£¬ÉúÎïËØ£¨biotin£©:²ÎÓëÍÑôÈ·´Ó¦µÄÒ»ÖÖøµÄ¸¨ÖúÒò×Ó¡£
12£¬¸¨Ã¸A(coenzyme A):Ò»ÖÖº¬ÓзºËáµÄ¸¨Ã¸£¬ÔÚijЩø´Ù·´Ó¦ÖÐ×÷Ϊõ£»ùµÄÔØÌå¡£
13£¬ÀàºúÂܲ·ËØ£¨carotenoid£©:ÓÉÒìÎì¶þÏ©×é³ÉµÄÖ¬ÈÜÐÔ¹âºÏÉ«ËØ¡£
14£¬×ª°±Ã¸£¨transaminase£©:ÄdzÆÎª°±»ù×ªÒÆÃ¸£¬ÔÚ¸ÃøµÄ´ß»¯Ï£¬Ò»¸ö¦Á-°±»ùËáµÄ°±»ù¿É×ªÒÆ¸ø±ðÒ»¸ö¦Á-ͪËá¡£
µÚÎåÕÂ
1£¬È©ÌÇ£¨aldose£©:Ò»À൥ÌÇ£¬¸Ãµ¥ÌÇÖÐÑõ»¯Êý×î¸ßµÄCÔ­×Ó£¨Ö¸¶¨ÎªC-1£©ÊÇÒ»¸öÈ©»ù¡£
2£¬ÍªÌÇ£¨ketose£©:Ò»À൥ÌÇ£¬¸Ãµ¥ÌÇÖÐÑõ»¯Êý×î¸ßµÄCÔ­×Ó£¨Ö¸¶¨ÎªC-2£©ÊÇÒ»¸öͪ»ù¡£
3£¬ÒìÍ·Îanomer£©:½öÔÚÑõ»¯Êý×î¸ßµÄCÔ­×Ó£¨Òìͷ̼£©ÉϾßÓв»Í¬¹¹ÐεÄÌÇ·Ö×ÓµÄÁ½ÖÖÒì¹¹Ìå¡£
4£¬Òìͷ̼£¨anomer carbon£©:»·»¯µ¥ÌǵÄÑõ»¯Êý×î¸ßµÄCÔ­×Ó£¬Òìͷ̼¾ßÓÐôÊ»ùµÄ»¯Ñ§·´Ó¦ÐÔ¡£
5£¬±äÐý£¨mutarotation£©:ßÁà«ÌÇ£¬ß»à«ÌÇ»òÌÇÜÕ°éËæËüÃǵĦÁ-ºÍ¦Â-Òì¹¹ÐÎʽµÄƽºâ¶ø·¢ÉúµÄ±ÈÐý¶È±ä»¯¡£
6£¬µ¥ÌÇ£¨monosaccharide£©:ÓÉ3¸ö»ò¸ü¶à̼ԭ×Ó×é³ÉµÄ¾ßÓо­Ñ鹫ʽ£¨CH2O£©nµÄ¼òÌÇ¡£
7£¬ÌÇÜÕ£¨dlycoside£©:µ¥ÌǰëËõÈ©ôÇ»ùÓë±ðÒ»¸ö·Ö×ÓµÄôÇ»ù£¬°·»ù»òÛÏ»ùËõºÏÐγɵĺ¬ÌÇÑÜÉúÎï¡£
8£¬ÌÇÜÕ¼ü£¨glycosidic bond£©:Ò»¸öÌǰëËõÈ©ôÇ»ùÓëÁíÒ»¸ö·Ö×Ó£¨ÀýÈç´¼¡¢ÌÇ¡¢àÑßÊ»òà×ण©µÄôÇ»ù¡¢°·»ù»òÛÏ»ùÖ®¼äËõºÏÐγɵÄËõÈ©»òËõͪ¼ü£¬³£¼ûµÄÌÇÈ©¼üÓÐO-ÌÇÜÕ¼üºÍN-ÌÇÜÕ¼ü¡£
9£¬¹ÑÌÇ£¨oligoccharide£©:ÓÉ2¡«20¸öµ¥ÌDzлùͨ¹ýÌÇÜÕ¼üÁ¬½ÓÐγɵľۺÏÎï¡£
10£¬¶àÌÇ£¨polysaccharide£©:20¸öÒÔÉϵĵ¥ÌÇͨ¹ýÌÇÜÕ¼üÁ¬½ÓÐγɵľۺÏÎï¡£¶àÌÇÁ´¿ÉÒÔÊÇÏßÐεĻò´øÓзÖÖ§µÄ¡£
11£¬»¹Ô­ÌÇ£¨reducing sugar£©:ôÊ»ù̼£¨Òìͷ̼£©Ã»ÓвÎÓëÐγÉÌÇÜÕ¼ü£¬Òò´Ë¿É±»Ñõ»¯³äµ±»¹Ô­¼ÁµÄÌÇ¡£
12£¬µí·Û£¨starch£©:Ò»Àà¶àÌÇ£¬ÊÇÆÏÌÑÌDzлùµÄͬ¾ÛÎï¡£ÓÐÁ½ÖÖÐÎʽµÄµí·Û:Ò»ÖÖÊÇÖ±Á´µí·Û£¬ÊÇûÓзÖÖ§µÄ£¬Ö»ÊÇͨ¹ý¦Á-£¨1¡ú4£©ÌÇÜÕ¼üµÄÆÏÌÑÌDzлùµÄ¾ÛºÏÎÁíÒ»ÀàÊÇÖ§Á´µí·Û£¬ÊǺ¬ÓзÖÖ§µÄ£¬¦Á-£¨1¡ú4£©ÌÇÜÕ¼üÁ¬½ÓµÄÆÏÌÑÌDzлùµÄ¾ÛºÏÎ֧Á´ÔÚ·ÖÖ§´¦Í¨¹ý¦Á-£¨1¡ú6£©ÌÇÜÕ¼üÓëÖ÷Á´ÏàÁ¬¡£
13£¬ÌÇÔ­£¨glycogen£©: ÊǺ¬ÓзÖÖ§µÄ¦Á-£¨1¡ú4£©ÌÇÜÕ¼üµÄÆÏÌÑÌDzлùµÄͬ¾ÛÎ֧Á´ÔÚ·ÖÖ§µã´¦Í¨¹ý¦Á-£¨1¡ú6£©ÌÇÜÕ¼üÓëÖ÷Á´ÏàÁ¬¡£
14£¬¼«ÏÞºý¾«£¨limit dexitrin£©:ÊÇÖ¸Ö§Á´µí·ÛÖдøÓÐÖ§Á´µÄºËÐIJ¿Î»£¬¸Ã²¿·Ö¾­Ö§Á´µí·Ûøˮ½â×÷Óã¬ÌÇÔ­Á×Ëữø»òµí·ÛÁ×Ëữø×÷ÓúóÈÔÈ»´æÔÚ¡£ºý¾«µÄ½øÒ»²½½µ½âÐèÒª¦Á-£¨1¡ú6£©ÌÇÜÕ¼üµÄË®½â¡£
15£¬ëľÛÌÇ£¨peptidoglycan£©:N-ÒÒõ£ÆÏÌÑÌǰ·ºÍN-ÒÒõ£ÍÙÒºËá½»ÌæÁ¬½ÓµÄÔÓ¶àÌÇÓ벻ͬµÄ뼻²æÁ¬½ÓÐγɵĴó·Ö×Ó¡£ëľÛÌÇÊÇÐí¶àϸ¾úϸ°û±ÚµÄÖ÷Òª³É·Ö¡£
16£¬Ìǵ°°×£¨glycoprotein£©:º¬Óй²¼ÛÁ¬½ÓµÄÆÏÌÑÌDzлùµÄµ°°×ÖÊ¡£
17£¬µ°°×¾ÛÌÇ£¨proteoglycan£©:ÓÉÔÓ¶àÌÇÓëÒ»¸ö¶àëÄÁ¬×é³ÉµÄÔÓ»¯µÄÔÚ·Ö×Ó£¬¶àÌÇÊÇ·Ö×ÓµÄÖ÷  µÚÁùÕÂ
1£¬Ö¬·¾Ëᣨfatty acid£©:ÊÇÖ¸Ò»¶Ëº¬ÓÐÒ»¸öôÈ»ùµÄ³¤µÄÖ¬·¾×å̼ÇâÁ´¡£Ö¬·¾ËáÊÇ×î¼òµ¥µÄÒ»ÖÖÖ¬£¬ËüÊÇÐí¶à¸ü¸´ÔÓµÄÖ¬µÄ³É·Ö¡£
2£¬±¥ºÍÖ¬·¾Ëᣨsaturated fatty acid£©:²»º¬ÓÐ-C=C-Ë«¼üµÄÖ¬·¾Ëá¡£
3£¬²»±¥ºÍÖ¬·¾Ëᣨunsaturated fatty acid£©:ÖÁÉÙº¬ÓÐ-C=C-Ë«¼üµÄÖ¬·¾Ëá¡£
4£¬±ØÐèÖ¬·¾Ëᣨoccential fatty acid£©:ά³Ö²¸È鶯ÎïÕý³£Éú³¤Ëù±ØÐèµÄ£¬¶ø¶¯ÎïÓÖ²»ÄܺϳɵÄÖ¬·¾ËᣬEgÑÇÓÍËᣬÑÇÂéËá¡£
5£¬ÈýÖ¬õ£ÜÕÓÍ£¨triacylglycerol£©:ÄdzÆÎª¸ÊÓÍÈýõ¥¡£Ò»ÖÖº¬ÓÐÓë¸ÊÓÍÖ¬»¯µÄÈý¸öÖ¬õ£»ùµÄõ¥¡£Ö¬·¾ºÍÓÍÊÇÈýÖ¬õ£¸ÊÓ͵ĻìºÏÎï¡£
6£¬Á×Ö¬£¨phospholipid£©:º¬ÓÐÁ×Ëá³É·ÖµÄÖ¬¡£EgÂÑÁ×Ö¬£¬ÄÔÁ×Ö¬¡£
7£¬ÇÊÖ¬£¨sphingolipid£©:Ò»ÀຬÓÐÇʰ±´¼¹Ç¼ÜµÄÁ½ÐÔÖ¬£¬Ò»¶ËÁ¬½Ó×ÅÒ»¸ö³¤Á¬µÄÖ¬·¾ËᣬÁíÒ»¶ËΪһ¸ö¼«ÐԺʹ¼¡£ÇÊÖ¬°üÀ¨ÇÊÁ×Ö¬£¬ÄÔÁ×Ö¬ÒÔ¼°Éñ¾­½ÚÜÕÖ¬£¬Ò»°ã´æÔÚÓÚÖ²ÎïºÍ¶¯Îïϸ°ûĤÄÚ£¬ÓÈÆäÊÇÔÚÖÐÊàÉñ¾­ÏµÍ³µÄ×éÖ¯ÄÚº¬Á¿·á¸»¡£
8£¬ÇÊÁ×Ö¬£¨sphingomyelin£©:Ò»ÖÖÓÉÉñ¾­õ£°·µÄC-1ôÇ»ùÉÏÁ¬½ÓÁËÁ×ËáëÀïÇ󵨼»òÁ×ËáÒÒõ£°·£©¹¹³ÉµÄÇÊÖ¬¡£ÇÊÁ×Ö¬´æÔÚÓÚÔÚ¶àÊý²¸È鶯ÎﶯÎïϸ°ûµÄÖÊĤÄÚ£¬ÊÇËèÇʵÄÖ÷Òª³É·Ö¡£
9£¬ÂÑÁ×Ö¬£¨lecithin£©:¼´Á×Ö¬õ£µ¨¼î£¨PC£©£¬ÊÇÁ×Ö¬õ£Ó뵨¼îÐγɵĸ´ºÏÎï¡£
10£¬ÄÔÁ×Ö¬£¨cephalin£©:¼´Á×Ö¬õ£ÒÒ´¼°·£¨PE£©£¬ÊÇÁ×Ö¬õ£ÓëÒÒ´¼°·Ðγɵĸ´ºÏÎï¡£
11£¬Ö¬ÖÊÌ壨liposome£©:ÊÇÓɰüΧˮÏà¿Õ¼äµÄÁ×֬˫²ãÐγɵÄÄÒÅÝ£¨Ð¡ÅÝ£©¡£
12£¬ÉúÎïĤ£¨bioligical membrane£©:ÏâǶÓе°°×ÖʵÄ֬˫²ã£¬Æð×Å»­·ÖºÍ·Ö¸ôϸ°ûºÍϸ°ûÆ÷×÷ÓÃÉúÎïĤҲÊÇÓëÐí¶àÄÜÁ¿×ª»¯ºÍϸ°ûÄÚͨѶÓйصÄÖØÒª²¿Î»¡£
13£¬ÄÚÔÚĤµ°°×£¨integral membrane protein£©:²åÈë֬˫²ãµÄÊèË®ºËºÍÍêÈ«¿çԽ֬˫²ãµÄĤµ°°×¡£
14£¬ÍâÖÜĤµ°°×£¨peripheral membrane protein£©:ͨ¹ýÓëĤ֬µÄ¼«ÐÔÍ·²¿»òÄÚÔÚµÄĤµ°°×µÄÀë×ÓÏ໥×÷ÓúÍÐγÉÇâ¼üÓëĤµÄÄÚ»òÍâ±íÃæÈõ½áºÏµÄĤµ°°×¡£
15£¬Á÷ÌåÏâǶģÐÍ£¨fluid mosaic model£©:Õë¶ÔÉúÎïĤµÄ½á¹¹Ìá³öµÄÒ»ÖÖÄ£ÐÍ¡£ÔÚÕâ¸öÄ£ÐÍÖУ¬ÉúÎïĤ±»ÃèÊö³ÉÏâǶÓе°°×ÖʵÄÁ÷Ìå֬˫²ã£¬Ö¬Ë«²ãÔڽṹºÍ¹¦ÄÜÉ϶¼±íÏÖ³ö²»¶Ô³ÆÐÔ¡£Óеĵ°°×ÖÊ¡°Ïâ¡°ÔÚ֬˫²ã±íÃæ£¬ÓеÄÔò²¿·Ö»òÈ«²¿Ç¶ÈëÆäÄÚ²¿£¬ÓеÄÔòºá¿çÕû¸öĤ¡£ÁíÍâÖ¬ºÍĤµ°°×¿ÉÒÔ½øÐкáÏòÀ©É¢¡£
16£¬Í¨Í¸ÏµÊý£¨permeability coefficient£©:ÊÇÀë×Ó»òС·Ö×ÓÀ©É¢¹ý֬˫²ãĤÄÜÁ¦µÄÒ»ÖÖÁ¿¶È¡£Í¨Í¸ÏµÊý´óСÓëÕâЩÀë×Ó»ò·Ö×ÓÔڷǼ«ÐÔÈÜÒºÖеÄÈܽâ¶È³É±ÈÀý¡£
17£¬Í¨µÀµ°°×£¨channel protein£©:ÊÇ´øÓÐÖÐÑëË®ÏàͨµÀµÄÄÚÔÚĤµ°°×£¬Ëü¿ÉÒÔʹ´óСÊʺϵÄÀë×Ó»ò·Ö×Ó´ÓĤµÄÈÎÒ»·½Ïò´©¹ýĤ¡£
18£¬£¨Ä¤£©¿×µ°°×£¨pore protein£©:Æäº¬ÒâÓëĤͨµÀµ°°×ÀàËÆ£¬Ö»ÊǸÃÊõÓï³£ÓÃÓÚϸ¾ú¡£
19£¬±»¶¯×ªÔË£¨passive transport£©:ÄdzÆÎªÒ×»¯À©É¢¡£ÊÇÒ»ÖÖתÔË·½Ê½£¬Í¨¹ý¸Ã·½Ê½ÈÜÖÊÌØÒìµÄ½áºÏÓÚÒ»¸öתÔ˵°°×ÉÏ£¬È»ºó±»×ªÔ˹ýĤ£¬µ«×ªÔËÊÇÑØ×ÅŨ¶ÈÌݶÈϽµ·½Ïò½øÐеģ¬ËùÒÔ±»¶¯×ª´ï²»ÐèÒªÄÜÁ¿µÄÖ§³Ö¡£
20£¬Ö÷¶¯×ªÔË£¨active transport£©:Ò»ÖÖתÔË·½Ê½£¬Í¨¹ý¸Ã·½Ê½ÈÜÖÊÌØÒìµÄ½áºÏÓÚÒ»¸öתÔ˵°°×ÉÏÈ»ºó±»×ªÔ˹ýĤ£¬Óë±»¶¯×ªÔËÔËÊ䷽ʽÏà·´£¬Ö÷¶¯×ªÔËÊÇÄæ×ÅŨ¶ÈÌݶÈϽµ·½Ïò½øÐеģ¬ËùÒÔÖ÷¶¯×ªÔËÐèÒªÄÜÁ¿µÄÇý¶¯¡£ÔÚÔ­·¢Ö÷¶¯×ªÔ˹ý³ÌÖÐÄÜÔ´¿ÉÒÔÊǹ⣬ATP»òµç×Ó´«µÝ£»¶øµÚ¶þ¼¶Ö÷¶¯×ªÔËÊÇÔÚÀë×ÓŨ¶ÈÌݶÈϽøÐеġ£
21£¬Ð­Í¬ÔËÊ䣨contransport£©:Á½ÖÖ²»Í¬ÈÜÖʵĿçĤµÄñîÁª×ªÔË¡£¿ÉÒÔͨ¹ýÒ»¸öתÔ˵°°×½øÐÐͬһ·½Ïò£¨Í¬ÏòתÔË£©»ò·´·½Ïò£¨·´ÏòתÔË£©×ªÔË¡£
22£¬°ûÍÌ£¨ÐÅÓã©£¨endocytosis£©:ÎïÖʱ»ÖÊĤÍÌÈë²¢ÒÔĤÑÜÉú³öµÄÖ¬ÄÒÅÝÐγɣ¨ÎïÖÊÔÚÄÒÅÝÄÚ£©±»´øÈ뵽ϸ°ûÄڵĹý³Ì¡£
µÚÆßÕÂ
1£¬ºËÜÕ£¨nucleoside£©:ÊÇàÑßÊ»òà×़îͨ¹ý¹²¼Û¼üÓëÎìÌÇÁ¬½Ó×é³ÉµÄ»¯ºÏÎï¡£ºËÌÇÓë¼î»ùÒ»°ã¶¼ÊÇÓÉÌǵÄÒìͷ̼Óëà×वÄN-1»òàÑßʵÄN-9Ö®¼äÐγɵĦÂ-N-ÌǼüÁ¬½Ó¡£
2£¬ºËÜÕËᣨuncleoside£©:ºËÜÕµÄÎìÌdzɷÖÖеÄôÇ»ùÁ×ËữÐγɵϝºÏÎï¡£
3£¬cAMP(cycle AMP):3¨@,5¨@-»·ÏÙÜÕËᣬÊÇϸ°ûÄڵĵڶþÐÅʹ£¬ÓÉÓÚij²¿Ð©¼¤ËØ»òÆäËü·Ö×ÓÐźŴ̼¤¼¤»îÏÙÜÕËá»·»¯Ã¸´ß»¯ATP»·»¯Ðγɵġ£
4£¬Á×Ëá¶þÖ¬¼ü£¨phosphodiester linkage£©:Ò»ÖÖ»¯Ñ§»ùÍÅ£¬Ö¸Ò»·Ö×ÓÁ×ËáÓëÁ½¸ö´¼£¨ôÇ»ù£©õ¥»¯ÐγɵÄÁ½¸öõ¥¼ü¡£¸Ãõ¥¼ü³ÉÁËÁ½¸ö´¼Ö®¼äµÄÇÅÁº¡£ÀýÈçÒ»¸öºËÜÕµÄ3¨@ôÇ»ùÓë±ðÒ»¸öºËÜÕµÄ5¨@ôÇ»ùÓëͬһ·Ö×ÓÁ×Ëáõ¥»¯£¬¾ÍÐγÉÁËÒ»¸öÁ×Ëá¶þÖ¬¼ü¡£
5£¬ÍÑÑõºËÌǺËËᣨDNA£©:º¬ÓÐÌØÊâÍÑÑõºËÌǺËÜÕËáÐòÁеľÛÍÑÑõºËÜÕËᣬÍÑÑõºËÜÕËáÖ®¼äÊÇÊÇͨ¹ý3¨@,5¨@-Á×Ëá¶þÖ¬¼üÁ¬½ÓµÄ¡£DNAÊÇÒÅ´«ÐÅÏ¢µÄÔØÌå¡£
6£¬ºËÌǺËËᣨRNA£©:ͨ¹ý3¨@,5¨@-Á×Ëá¶þÖ¬¼üÁ¬½ÓÐγɵÄÌØÊâºËÌǺËÜÕËáÐòÁеľۺËÌǺËÜÕËá¡£
7£¬ºËÌÇÌåºËÌǺËËᣨRrna,ribonucleic acid£©:×÷Ϊ×é³É³É·ÖµÄÒ»Àà RNA£¬rRNAÊÇϸ°ûÄÚ×î ·á¸»µÄ RNA .
8£¬ÐÅʹºËÌǺËËá(mRNA,messenger ribonucleic acid):Ò»ÀàÓÃ×÷µ°°×ÖʺϳÉÄ£°åµÄRNA .
9, ×ªÒÆºËÌǺËËᣨTrna,transfer ribonucleic acid£©:Ò»ÀàЯ´ø¼¤»î°±»ùËᣬ½«Ëü´øµ½µ°°×Öʺϳɲ¿Î»²¢½«°±»ùËáÕûºÏµ½Éú³¤×ŵÄëÄÁ´ÉÏRNA¡£TRNAº¬ÓÐÄÜʶ±ðÄ£°åmRNAÉÏ»¥²¹ÃÜÂëµÄ·´ÃÜÂë¡£
10£¬×ª»¯£¨×÷Óã©£¨transformation£©:Ò»¸öÍâÔ´DNA ͨ¹ýijÖÖ;¾¶µ¼ÈëÒ»¸öËÞÖ÷¾ú£¬ÒýÆð¸Ã¾úµÄÒÅ´«ÌØÐԸıäµÄ×÷Óá£
11£¬×ªµ¼£¨×÷Óã©£¨transduction£©:½èÖúÓÚ²¡¶¾ÔØÌ壬ÒÅ´«ÐÅÏ¢´ÓÒ»¸öϸ°û×ªÒÆµ½ÁíÒ»¸öϸ°û¡£
12£¬¼î»ù¶Ô£¨base pair£©:ͨ¹ý¼î»ùÖ®¼äÇâ¼üÅä¶ÔµÄºËËáÁ´ÖеÄÁ½¸öºËÜÕËᣬÀýÈçAÓëT»òU , ÒÔ¼°GÓëCÅä¶Ô ¡£
13£¬Ïĸñ·ò·¨Ôò£¨Chargaff¡¯s rules£©:ËùÓÐDNAÖÐÏÙàÑßÊÓëÐØÏÙà×वÄĦ¶ûº¬Á¿ÏàµÈ£¨A=T£©£¬ÄñàÑßʺͰûà×वÄĦ¶ûº¬Á¿ÏàµÈ£¨G=C£©£¬¼ÈàÑßʵÄ×ܺ¬Á¿ÏàµÈ£¨A+G=T+C£©¡£DNAµÄ¼î»ù×é³É¾ßÓÐÖÖµÄÌØÒìÐÔ£¬µ«Ã»ÓÐ×éÖ¯ºÍÆ÷¹ÙµÄÌØÒìÐÔ¡£ÁíÍ⣬Éú³¤ºÍ·¢Óý½×¶Î`ÓªÑø×´Ì¬ºÍ»·¾³µÄ¸Ä±ä¶¼²»Ó°ÏìDNAµÄ¼î»ù×é³É¡£
14£¬DNAµÄË«ÂÝÐý£¨DNAdouble helix£©:Ò»ÖÖºËËáµÄ¹¹Ïó£¬Ôڸù¹ÏóÖУ¬Á½Ìõ·´ÏòƽÐеĶàºË¸ÊËáÁ´Ï໥²øÈÆÐγÉÒ»¸öÓÒÊÖµÄË«ÂÝÐý½á¹¹¡£¼î»ùλÓÚË«ÂÝÐýÄڲ࣬Á×ËáÓëÌÇ»ùÔÚÍâ²à£¬Í¨¹ýÁ×Ëá¶þÖ¬¼üÏàÁ¬£¬ÐγɺËËáµÄ¹Ç¼Ü¡£¼î»ùÆ½ÃæÓë¼ÙÏóµÄÖÐÐÄÖá´¹Ö±£¬ÌÇ»·Æ½ÃæÔòÓëÖáÆ½ÐУ¬Á½ÌõÁ´½ÔΪÓÒÊÖÂÝÐý¡£Ë«ÂÝÐýµÄÖ±¾¶Îª2nm£¬¼î»ù¶Ñ»ý¾àÀëΪ0.34nm£¬ Á½ºË¸ÊËáÖ®¼äµÄ¼Ð½ÇÊÇ36©b£¬Ã¿¶ÔÂÝÐýÓÉ10¶Ô¼î»ù×é³É£¬¼î»ù°´A-T£¬G-CÅä¶Ô»¥²¹£¬±Ë´ËÒÔÇâ¼üÏàÁªÏµ¡£Î¬³ÖDNAË«ÂÝÐý½á¹¹µÄÎȶ¨µÄÁ¦Ö÷ÒªÊǼî»ù¶Ñ»ýÁ¦¡£Ë«ÂÝÐý±íÃæÓÐÁ½Ìõ¿íÕ­`Éîdz²»Ò»µÄÒ»¸ö´ó¹µºÍÒ»¸öС¹µ¡£
15.´ó¹µ£¨major groove£©ºÍС¹µ£¨minor groove£©:ÈÆB-DNAË«ÂÝÐý±íÃæÉϳöÏÖµÄÂÝÐý²Û£¨¹µ£©£¬¿íµÄ¹µ³ÆÎª´ó¹µ£¬Õ­¹µ³ÆÎªÐ¡¹µ¡£´ó¹µ£¬Ð¡¹µ¶¼¡¢ÊÇÓÉÓÚ¼î»ù¶Ô¶Ñ»ýºÍÌÇ-Á×Ëá¹Ç¼ÜŤתÔì³ÉµÄ¡£
16.DNA³¬ÂÝÐý£¨DNAsupercoiling£©NA±¾ÉíµÄ¾íÇúÒ»°ãÊÇDNAË«`ÂÝÐýµÄÍäÇúÇ·Ðý£¨¸º³¬ÂÝÐý£©»ò¹ýÐý£¨Õý³¬ÂÝÐý£©µÄ½á¹û¡£
17.ÍØÆËÒ칹ø£¨topoisomerse£©:ͨ¹ýÇжÏDNAµÄÒ»Ìõ»òÁ½ÌõÁ´ÖеÄÁ×Ëá¶þõ¥¼ü£¬È»ºóÖØÐ²øÈƺͷâ¿ÚÀ´¸Ä±äDNAÁ¬»·ÊýµÄø¡£ÍØÆËÒ칹ø¢ñ¡¢Í¨¹ýÇжÏDNAÖеÄÒ»ÌõÁ´¼õÉÙ¸º³¬ÂÝÐý£¬Ôö¼ÓÒ»¸öÁ¬»·Êý¡£Ä³Ð©ÍØÆËÒ칹ø¢òÒ²³ÆÎªDNA´ÙÐýø¡£
18.ºËСÌ壨nucleosome£©:ÓÃÓÚ°üװȾɫÖʵĽṹµ¥Î»£¬ÊÇÓÉDNAÁ´²øÈÆÒ»¸ö×éµ°°×ºË¹¹³ÉµÄ¡£
19.ȾɫÖÊ£¨chromatin£©: ÊÇ´æÔÚÓëÕæºËÉúÎï¼äÆÚϸ°ûºËÄÚ£¬Ò×±»¼îÐÔȾÁÏ×ÅÉ«µÄÒ»ÖÖÎÞ¶¨ÐÎÎïÖÊ¡£È¾É«ÖÊÖк¬ÓÐ×÷Ϊ¹Ç¼ÜµÄÍêÕûµÄË«Á´DNA£¬ÒÔ¼°×éµ°°×`·Ç×éµ°°×ºÍÉÙÁ¿µÄDNA¡£
20.ȾɫÌ壨chromosome£©:ÊÇȾɫÖÊÔÚϸ°û·ÖÁѹý³ÌÖо­¹ý½ôÃܲøÈÆ`ÕÛµþ`ÄýËõºÍ¾«Ï¸°ü×°ÐγɵľßÓй̶¨ÐÎ̬µÄÒÅ´«ÎïÖÊ´æÔÚÐÎʽ¡£¼ò¶øÑÔÖ®£¬È¾É«ÌåÊÇÒ»¸ö´óµÄµ¥Ò»µÄË«Á´DNA·Ö×ÓÓëÏà¹Øµ°°×ÖÊ×é³ÉµÄ¸´ºÏÎDNAÖк¬ÓÐÐí¶àÖü´æºÍ´«µÝÒÅ´«ÐÅÏ¢µÄ»ùÒò¡£
21.DNA±äÐÔ£¨DNAdenaturation£©NAË«Á´½âÁ´£¬·ÖÀë³ÉÁ½Ìõµ¥Á´µÄÏÖÏó¡£
22.ÍË»ð£¨annealing£©:¼ÈDNAÓɵ¥Á´¸´ÐÔ¡¢±ä³ÉË«Á´½á¹¹µÄ¹ý³Ì¡£À´Ô´ÏàͬµÄDNAµ¥Á´¾­ÍË»ðºóÍêÈ«»Ö¸´Ë«Á´½á¹¹µÄ¹ý³Ì£¬Í¬Ô´DNAÖ®¼ä`DNAºÍRNAÖ®¼ä£¬ÍË»ðºóÐγÉÔÓ½»·Ö×Ó¡£
23.ÈÛ½âζȣ¨melting temperature,Tm£©:Ë«Á´DNAÈ۽⳹µ×±ä³Éµ¥Á´DNAµÄζȷ¶Î§µÄÖеãζȡ£
24.ÔöɫЧӦ£¨hyperchromic effect£©:µ±Ë«ÂÝÐýDNAÈ۽⣨½âÁ´£©Ê±£¬260nm´¦×ÏÍâÎüÊÕÔö¼ÓµÄÏÖÏó¡£
25.¼õɫЧӦ£¨hypochromic effect£©:Ëæ×źËËḴÐÔ£¬×ÏÍâÎüÊÕ½µµÍµÄÏÖÏó¡£
26.ºËËáÄÚÇÐø£¨exonuclease£©: ºËÌǺËËáøºÍÍÑÑõºËÌǺËËáøÖÐÄܹ»Ë®½âºËËá·Ö×ÓÄÚÁ×Ëá¶þõ¥¼üµÄø¡£
27.ºËËáÍâÇÐø£¨exonuclease£©:´ÓºËËáÁ´µÄÒ»¶ËÖð¸öË®½âºË¸ÊËáµÄø¡£
28.ÏÞÖÆÐÔÄÚÇÐø£¨restriction endonuclease£©:Ò»ÖÖÔÚÌØÊâºË¸ÊËáÐòÁд¦Ë®½âË«Á´DNAµÄÄÚÇÐø¡£¢ñÐÍÏÞÖÆÐÔÄÚÇÐø¼ÈÄÜ´ß»¯ËÞÖ÷DNAµÄ¼×»ù»¯£¬ÓÖ´ß»¯·Ç¼×»ù»¯µÄDNAµÄË®½â£»¶ø¢òÐÍÏÞÖÆÐÔÄÚÇÐøֻ´ß»¯·Ç¼×»ù»¯µÄDNAµÄË®½â¡£
29.ÏÞÖÆÃ¸Í¼Æ×£¨restriction map£©:ͬһDNAÓò»Í¬µÄÏÞÖÆÃ¸½øÐÐÇи´Ó¶ø»ñµÃ¸÷ÖÖÏÞÖÆÃ¸µÄÇиîλµã£¬Óɴ˽¨Á¢µÄλµãͼÆ×ÓÐÖúÓÚ¶ÔDNAµÄ½á¹¹½øÐзÖÎö¡£
30.·´ÏòÖØ¸´ÐòÁУ¨inverted repeat sequence£©:ÔÚͬһ¶àºË¸ÊËáÄÚµÄÏà·´·½ÏòÉÏ´æÔÚµÄÖØ¸´µÄºË¸ÊËáÐòÁС£ÔÚË«Á´DNAÖз´ÏòÖØ¸´¿ÉÄÜÒýÆðÊ®×ÖÐνṹµÄÐγɡ£
31.ÖØ×éDNA¼¼Êõ£¨recombination DNA technology£©:Ò²³ÆÖ®Îª»ùÒò¹¤³Ì£¨genomic engineering£©.ÀûÓÃÏÞÖÆÐÔÄÚÇÐøºÍÔØÌ壬°´ÕÕÔ¤ÏÈÉè¼ÆµÄÒªÇ󣬽«Ò»ÖÖÉúÎïµÄijÖÖÄ¿µÄ»ùÒòºÍÔØÌåDNAÖØ×éºóתÈëÁíÒ»ÉúÎïϸ°ûÖнøÐи´ÖÆ`ת¼ºÍ±í´ïµÄ¼¼Êõ¡£
32.»ùÒò£¨gene£©:Ò²³ÆÎªË³·´×Ó£¨cistron£©.·ºÖ¸±»×ªÂ¼µÄÒ»¸öDNAƬ¶Î¡£ÔÚijЩÇé¿öÏ£¬»ùÒò³£ÓÃÀ´Ö¸±àÂëÒ»¸ö¹¦Äܵ°°×»òDNA·Ö×ÓµÄDNAƬ¶Î¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jdklgjldg

ľ³æ (ÕýʽдÊÖ)

1

ÔÙ½ÓÔÙÀ÷
ÎÒµÄÄ¿±ê:ŵ±´¶ûҽѧÓëÉúÀíѧ½±
2Â¥2006-04-13 10:45:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1

3Â¥2006-04-24 15:16:18
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

etingtian

Ìú³æ (СÓÐÃûÆø)

ÓÐûÓйØÓÚ¸¨Ã¸Q10µÄ×ÊÁÏ

ÓÐûÓйØÓÚ¸¨Ã¸Q10µÄ×ÊÁÏ
4Â¥2006-12-26 14:04:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ mengzhongmeng µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á +6 Á«²Ë¾ÍÊÇź°É 2026-04-03 6/300 2026-04-04 08:50 by ßÕßÕßÕßÉßÉßÉ
[¿¼ÑÐ] 317·Ö Ò»Ö¾Ô¸½­ÄÏ´óѧ »¯Ñ§¹¤³Ìѧ˶ Çóµ÷¼Á +6 YinTai 2026-04-03 6/300 2026-04-03 22:30 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 350Ò»Ö¾Ô¸±±¾©º½¿Õº½Ìì´óѧ08500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +5 kjnasfss 2026-04-03 5/250 2026-04-03 22:29 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 085601Ò»Ö¾Ô¸±±Àí325·ÖÇóµ÷¼Á +6 ÕÒµ÷¼Á£¬£¬ 2026-04-02 6/300 2026-04-03 22:20 by –¹Æ?
[¿¼ÑÐ] 285Çóµ÷¼Á +7 AZMK 2026-04-02 9/450 2026-04-03 11:12 by wanwan00
[¿¼ÑÐ] 316Çóµ÷¼Á +14 ÖÛ×Ô¹£ 2026-04-01 18/900 2026-04-03 10:28 by linyelide
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +6 ´Þwj 2026-04-02 6/300 2026-04-03 10:19 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 085602 ÕÒµ÷¼Á +3 ÄæÊ±Õë¿ìÀÖ 2026-04-02 3/150 2026-04-02 21:23 by dongzh2009
[¿¼ÑÐ] 342Çóµ÷¼Á +16 Mary Keen 2026-03-28 17/850 2026-04-02 21:14 by 690616278
[¿¼ÑÐ] 348Çóµ÷¼Á +11 zzzzyk123 2026-04-01 11/550 2026-04-02 16:52 by Wang200018
[¿¼ÑÐ] 346Çóµ÷¼Á +5 Ö£³ÏÀÖ 2026-04-02 5/250 2026-04-02 16:38 by SZW_UJN
[¿¼ÑÐ] 348Çóµ÷¼Á +6 ÎâÑå׿24k 2026-04-02 6/300 2026-04-02 14:07 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] 272Çóµ÷¼Á£¬½ÓÊÜ¿çרҵµ÷¼Á£¡ +4 ÏÐÓ㬠2026-03-31 4/200 2026-04-02 11:18 by guyan1000
[¿¼ÑÐ] 0805Çóµ÷¼Á +8 ÊÇË®·Ö 2026-03-31 8/400 2026-04-02 10:46 by guanxin1001
[¿¼ÑÐ] 385·Ö ÉúÎïѧ£¨071000£©Çóµ÷¼Á +6 qf626 2026-04-01 6/300 2026-04-02 10:39 by guoweigw
[¿¼ÑÐ] ²ÄÁÏÇóµ÷¼Á +8 ÄØÄØÄÝÄÝ 2026-04-01 8/400 2026-04-02 07:13 by yjolah
[¿¼ÑÐ] 080200ѧ˶£¬»úе¹¤³Ìרҵ277·Ö£¬Çó´ø×ߣ¡ +4 Æ¿×ÓPZ 2026-03-31 4/200 2026-03-31 20:16 by vgtyfty
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á +6 hanamiko 2026-03-29 6/300 2026-03-31 16:35 by hypershenger
[¿¼ÑÐ] ²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +10 hyl3153942 2026-03-29 10/500 2026-03-31 16:31 by hypershenger
[¿¼ÑÐ] ¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤×¨Ë¶378Çóµ÷¼Á +3 Ëþ±ÈÎÚ˹ 2026-03-30 3/150 2026-03-30 22:55 by Î޼ʵIJÝÔ­
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û